Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 62332-794

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 62332-794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figue 1 (Venlafaxine 1 Figure)

A scatter plot chart showing fold changes with 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax and AUC) across various special populations and conditions, including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents change relative to the reference value.*

FDA Label Image

30 Capsules (Venlafaxine 150 mg)

The label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Alembic Pharmaceuticals Inc. It indicates the product is prescription-only, in an oral extended-release capsule form, with a package containing 30 capsules. The label includes storage instructions, manufacturer details, a barcode, and a note on child-resistant packaging.*

FDA Label Image

Figure 2 (Venlafaxine 2 Figure)

A forest plot chart depicting the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its analyte in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The chart shows the relative change compared to a reference value for each drug interaction.*

FDA Label Image

Figure 3 (Venlafaxine 3 Figure)

A scatter plot chart depicting the fold change and 90% confidence intervals for various analytes interacting with different drugs. The chart plots fold change relative to a reference value on the horizontal axis and lists multiple interacting drugs with their corresponding analytes, pharmacokinetic parameters (Cmax, AUC), and fold changes with error bars.*

FDA Label Image

30 Capsules (Venlafaxine 37 5 mg)

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg, capsule dosage form. The label shows 30 capsules per package. Manufactured by Alembic Pharmaceuticals Limited in India and labeled for Alembic Pharmaceuticals, Inc., USA. Includes NDC 62332-792-30 and a barcode. Storage instructions and a pharmacist dispensing note are also visible.*

FDA Label Image

30 Capsules (Venlafaxine 75 mg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg by Alembic Pharmaceuticals Inc. The label states the product is a prescription oral capsule, with 30 capsules per unit. It includes dosage information, manufacturer details for Alembic Pharmaceuticals in India and USA, storage instructions, and a barcode with GTIN.*

FDA Label Image

Venlafaxine-structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, depicting its molecular arrangement including a cyclohexanol ring, methoxyphenyl group, and a dimethylaminoethyl side chain, with hydrochloride indicated as a separate entity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.